WILD-TYPE P53 ADOPTS A MUTANT-LIKE CONFORMATION WHEN BOUND TO DNA

被引:213
作者
HALAZONETIS, TD
DAVIS, LJ
KANDIL, AN
机构
[1] Department of Cancer Research, Merck Research Laboratories, West Point
关键词
CONFORMATIONAL SHIFT; DNA BINDING; P53; TUMOR SUPPRESSOR;
D O I
10.1002/j.1460-2075.1993.tb05743.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 is a negative regulator of cell growth. The majority of human tumors express mutant p53 proteins, which can be distinguished from wild-type by their immunoreactivity to a panel of conformation-specific monoclonal antibodies, such as PAb421, PAb1620 and PAb246. Wild-type p53 has sequence-specific DNA binding activity. We demonstrate that upon binding DNA wild-type p53 changes conformation at both its N- and C-termini, such that it adopts a 'mutant'-like conformation. Very few of the known DNA binding proteins exhibit long-range conformational changes upon binding to DNA. Such proteins, like the Drosophila heat shock transcription factor, have DNA binding domains whose activity is regulated by conformation. The DNA binding activity, and therefore the function, of wild-type p53 may be regulated via its ability to adopt distinct conformations.
引用
收藏
页码:1021 / 1028
页数:8
相关论文
共 55 条
  • [1] CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS
    BAKER, SJ
    FEARON, ER
    NIGRO, JM
    HAMILTON, SR
    PREISINGER, AC
    JESSUP, JM
    VANTUINEN, P
    LEDBETTER, DH
    BARKER, DF
    NAKAMURA, Y
    WHITE, R
    VOGELSTEIN, B
    [J]. SCIENCE, 1989, 244 (4901) : 217 - 221
  • [2] MONOCLONAL-ANTIBODIES AGAINST SIMIAN VIRUS-40 NUCLEAR LARGE T-TUMOR ANTIGEN - EPITOPE MAPPING, PAPOVA VIRUS CROSS-REACTION AND CELL-SURFACE STAINING
    BALL, RK
    SIEGL, B
    QUELLHORST, S
    BRANDNER, G
    BRAUN, DG
    [J]. EMBO JOURNAL, 1984, 3 (07) : 1485 - 1491
  • [3] WILD-TYPE BUT NOT MUTANT P53 IMMUNOPURIFIED PROTEINS BIND TO SEQUENCES ADJACENT TO THE SV40 ORIGIN OF REPLICATION
    BARGONETTI, J
    FRIEDMAN, PN
    KERN, SE
    VOGELSTEIN, B
    PRIVES, C
    [J]. CELL, 1991, 65 (06) : 1083 - 1091
  • [4] EVIDENCE FOR ALLOSTERIC VARIANTS OF WILD-TYPE-P53, A TUMOR SUPPRESSOR PROTEIN
    COOK, A
    MILNER, J
    [J]. BRITISH JOURNAL OF CANCER, 1990, 61 (04) : 548 - 552
  • [5] DEFROMENTEL CC, 1992, GENE CHROMOSOME CANC, V4, P1
  • [6] DEFINITION OF A CONSENSUS BINDING-SITE FOR P53
    ELDEIRY, WS
    KERN, SE
    PIETENPOL, JA
    KINZLER, KW
    VOGELSTEIN, B
    [J]. NATURE GENETICS, 1992, 1 (01) : 45 - 49
  • [7] PARTICIPATION OF P53 CELLULAR TUMOR-ANTIGEN IN TRANSFORMATION OF NORMAL EMBRYONIC-CELLS
    ELIYAHU, D
    RAZ, A
    GRUSS, P
    GIVOL, D
    OREN, M
    [J]. NATURE, 1984, 312 (5995) : 646 - 649
  • [8] WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION
    ELIYAHU, D
    MICHALOVITZ, D
    ELIYAHU, S
    PINHASIKIMHI, O
    OREN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) : 8763 - 8767
  • [9] WILD-TYPE P53 ACTIVATES TRANSCRIPTION INVITRO
    FARMER, G
    BARGONETTI, J
    ZHU, H
    FRIEDMAN, P
    PRYWES, R
    PRIVES, C
    [J]. NATURE, 1992, 358 (6381) : 83 - 86
  • [10] PRESENCE OF A POTENT TRANSCRIPTION ACTIVATING SEQUENCE IN THE P53 PROTEIN
    FIELDS, S
    JANG, SK
    [J]. SCIENCE, 1990, 249 (4972) : 1046 - 1049